New Vitassium® FastChews
New Vitassium FastChews
Vitassium® Introduces Fast-absorbing Electrolyte Tablets for People Living with POTS and Other Chronic Conditions
As delicious, chewable tablets, Vitassium FastChews® offer more options for people who can benefit from extra sodium intake
Thousand Oaks, Calif. — February 28, 2022 — After nearly six years of supporting people living with certain chronic conditions, Vitassium is expanding its family of electrolyte products with the launch of FastChews, quick-absorbing and chewable tablets that provide an on-the-go option for those in need of extra sodium intake.
Vitassium is a medical food specifically formulated to provide sodium and potassium for the clinical dietary management of several conditions, including dysautonomia, postural orthostatic tachycardia syndrome (POTS), Ehlers-Danlos syndromes (EDS), cystic fibrosis and vasovagal syncope, among others, when increased plasma volume has been shown to be beneficial.
Several of these conditions, including some types of EDS and cystic fibrosis are rare, genetic diseases with few treatment options and no known cures. Others, such as POTS are not rare, but are not well known. Symptoms of POTS can vary from day to day, range from mild to debilitating, and can include nausea, fatigue, brain fog, pain, lightheadedness, temperature sensitivity and a rapid heartbeat. Diagnosis and treatment can be extremely challenging; for example, it takes nearly six years for a person with POTS to receive a diagnosis.
Some people with these conditions can benefit from increased sodium intake, under the guidance of their physician. Many forms of sodium supplementation can be harsh on the stomach, and in 2016, Vitassium launched as a flavorless capsule that relies on buffered electrolytes to help reduce stomach upset.
Today, Vitassium supports thousands of people each day, by helping to maintain and replenish electrolyte levels, reduce fatigue, and dizziness due to low blood pressure, as well as support healthy blood pressure. Vitassium is proud to be a Platinum Sponsor of Dysautonomia International, a non-profit that supports research, education and awareness of POTS and other autonomic nervous system disorders.
“We're grateful for Vitassium’s ongoing financial support of our mission and appreciate the work they've done over the years to develop innovative new products that help people with POTS and other forms of dysautonomia,” said Lauren Stiles, president of Dysautonomia International.
As an evolution of the original capsule product, Vitassium FastChews offer a new way to consume electrolytes on the go, in chewable tablet format. Available in two flavors – Fruit Punch and Grape – Vitassium FastChews do not require water for consumption and are designed to be kind to sensitive stomachs. Each two-tablet serving contains 125 mg of sodium and 25 mg of potassium. Vitassium FastChews are allergen-free, non-GMO, vegan and gluten-free.
“As a parent of two children living with POTS, Vitassium has been a part of my life both professionally and personally for many years,” said Stacey Greenberg, brand manager of Vitassium. ”It’s been rewarding to see how Vitassium has helped thousands of people manage some of their symptoms under the guidance of their doctor over the years. We are incredibly excited about the new Vitassium FastChews, which provide a new, great-tasting way to get electrolytes when you’re out on the go, or when you need extra sodium quickly.”
Anyone living with a chronic condition, as well as caregivers, can purchase Vitassium for 20% off by becoming a member of the Vitassium Club. The club is free to join and offers free shipping for larger orders, as well as regular updates on the latest research and company information.
Fruit Punch and Grape flavors are available in two sizes: 60-count bottles and 10-count resealable packets. Additional flavors of Vitassium FastChews are planned for later in 2022.
Learn more about dysautonomia and related conditions at Dysautonomia 101.
Launched in 2016, Vitassium® is a medical food specifically formulated to provide sodium and potassium for the clinical dietary management of Postural Orthostatic Tachycardia Syndrome (POTS), Ehlers-Danlos Syndrome (EDS), Cystic Fibrosis (CF), and Vasovagal Syncope, when increased plasma volume has been shown to be beneficial. More information is available at www.vitassium.com.
About Alete Active Nutrition
At Alete Active Nutrition, we believe in the health benefits of living an active life. Alete Active Nutrition LLC (formerly RoadRunner Holdings LLC) is creating a portfolio of athlete-focused sports nutrition brands, including SaltStick, Vitassium, JoJé Bar, and Bonk Breaker, that provide the people, prowess, and products to activate an athlete’s potential for a healthy life. Backed by American Pacific Group, Alete Nutrition hopes to build upon these investments with additional high-quality sports nutrition brands. Alete Nutrition is committed to the development and support of a diverse, inclusive, and collaborative community of athletes, and sees a tremendous opportunity to bring the benefits of athletics and sports nutrition to athletes of all sports, skill levels, genders, geographies, ethnicities, abilities, and backgrounds. Learn more at www.AleteNutrition.com.